Scientists have created a virtual model of the brain that daydreams like humans do. Researchers created the computer model based on the dynamics of brain cells and the many connections those cells make with their neighbors and with cells in other brain regions.
One in 100 babies worldwide is born with a disease caused by a single gene, according to the World Health Organization. Two genetics companies—Counsyl and GoodStart Genetics—are now using low-cost sequencing as a way to provide a more comprehensive look at parents’ genes than has previously been available.
As medical systems move from hospitals to homes and onto human bodies, designers need to realize their users are not professionals anymore. These new at-home users do not understand conditions that could impact measurements and the validity of measurements.
The American Association for Homecare warned today that the controversial Medicare bidding program for diabetic testing supplies is endangering beneficiaries by requiring the use of generic testing strips and monitors that are under scrutiny by physicians and the Food and Drug Administration for inaccurate readings.
On this episode of The Pulse, a device that helps train the brain to turn sounds into images, detecting cancer by imaging the consumption of sugar, biomedical applications for a new hydrogel, and a nanofiber mesh that treats tumors with both thermotherapy and chemotherapy.
Researchers from Boston University School of Medicine and George Washington University have developed a method to rapidly identify pathogenic species and strains causing illnesses, such as pneumonia, that could help lead to earlier detection of disease outbreaks and pinpoint effective treatments more quickly.
A collaboration of biologists, engineers, and material scientists at Brown University has found that jagged edges of graphene can easily pierce cell membranes, allowing graphene to enter the cell and disrupt normal function. Understanding the mechanical forces of nanotoxicity should help engineers design safer materials at the nanoscale.
Chemists from North Carolina State University have performed a DNA-based logic-gate operation within a human cell. The research may pave the way to more complicated computations in live cells, as well as new methods of disease detection and treatment.
Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that it has entered into a contract manufacturing agreement with EDP Biotech, a medical device company focused on the development and...
Putting medical devices on the network provides a large number of benefits, such as supporting telemedicine and the easy transfer of test results to electronic medical records (EMR) systems. However, putting these devices on a network also introduces a number of risks.
Cellular machine-to-machine communications are opening the door to a world of innovative new healthcare applications. With the ability to collect real-time data from people and devices anywhere, and at any time, healthcare organizations and technology vendors are creating useful applications that improve people’s health and well being.
Is there a brain area for mind-wandering? For religious experience? For reorienting attention? A recent study casts serious doubt on the evidence for these ideas, and rewrites the rules for neuroimaging. Brain mapping experiments attempt to identify the cognitive functions associated with discrete cortical regions.
It could mean no more having to check up on Mom or Dad every morning: Motion sensors on the wall and a monitor under the mattress one day might automatically alert you to early signs of trouble well before an elderly loved one gets sick or suffers a fall.
An instrument that quickly and more effectively analyzes complex biological and environmental samples was today named one of the past year's 100 most significant scientific and technological products or advances. The innovation was recognized by R&D Magazine in their annual R&D 100 Awards competition.
In a study reported in the July 1, 2013 Angewandte Chemie, a group of University of Illinois bioengineers have found a way to strongly adhere hydrogels to hydrophobic silicone substrates, an innovation that provides a valuable new tool for microscale biotechnology.
Inspired by studies demonstrating canine abilities to sniff out cancerous biomarkers, a team of U.K. researchers developed a scent-analysis device that they say can diagnose early signs of bladder cancer. In a test of nearly 100 urine samples, the device, called OdorReader, was 100% accurate in distinguishing which samples came from cancer patients.
Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has announced the issuance of two new U.S. patents. U.S. Patent No. 8,257,654 relates to the management of health data collected by point-of-care testing devices using a health report server. U.S. Patent No. 8,307,531 covers a method and apparatus for manufacturing disposable dry test strips.
EDP Biotech, the US-based developer of a blood test to detect the early stages of colon cancer called ColoMarker™, today announced its plans to commercialize the product and bring the new technology to market. Unlike other diagnostic tests currently in development, the ColoMarker test detects a level of CA11-19 antigen.
New Data From Partners Center For Connected Health Demonstrates Wireless Mobile Technology Improves Patient Engagement, OutcomesJuly 9, 2013 10:00 am | by PR Newswire | News | Comments
A recent study conducted by the Center for Connected Health demonstrated that wireless mobile technologies can positively impact patient engagement, clinical outcomes and operational workflow in remote monitoring programs. Patients using wireless mobile devices to collect and transmit their data to the Center's secure database more frequently measured their blood pressure and uploaded their data.
Early signs of Alzheimer’s disease can be detected years before diagnosis, according to researchers at Birmingham City University. The study found that sufferers of a specific type of cognitive impairment have an increased loss of cells in certain parts of the brain, which can be vital in detecting which patients will progress to a diagnosis of Alzheimer’s.
Biotech titan Roche acquired Boston, Mass.-based medical device company Constitutional Medical Investors for a reported $220 million plus possible milestones. The Swiss company intends to beef up its diagnostics arm, Roche Diagnostics, with CMI's technology and announced plans to open a Center for Excellence in Hematology at CMI's Boston location.
A new technique for detecting cancer by imaging the consumption of sugar with magnetic resonance imaging has been unveiled by UCL scientists. The breakthrough could provide a safer and simpler alternative to standard radioactive techniques and enable radiologists to image tumors in greater detail.
Itamar-Medical Announced Today That the AMA Has Awarded a CPT Category III Code to a Test Performed by Its EndoPATTM Proprietary DeviceJuly 8, 2013 8:00 am | by Business Wire | News | Comments
Itamar-Medical Ltd (TASE: ITAMAR), developer and marketer of the EndoPAT TM non-invasive device for the assessment of endothelial function, today announced that The AMA (American Medical Association) has awarded a CPT category III reimbursement code to a test performed by its EndoPAT proprietary device.
Designers should look for a company that not only provides the right silicon, but also development tools, software, and support that are tailored for two main phases of a typical smartphone/tablet-based medical design. The first phase consists of the smartphone interface, and the second phase is the design of the medical device itself.
The exciting growth the medical telemonitoring sector has seen recently is impressive. According to Frost & Sullivan, the industry is expected to exceed double the revenues of previous years. The reason for this growth is twofold: necessity and innovation.